Quality of Life and Illness Acceptance among End-Stage Renal Disease (ESRD) Patients on Hemodialysis: The Moderating Effect of Death Anxiety during COVID-19 pandemic

• Published in: Omega: Journal of Death and Dying Vol. 89; no. 2; pp. 567 - 586
• Main Authors: Mushtaque, Iqra, Awais-E-Yazdan, Muhammad, Zahra, Rabab, Anas, Muhammad
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 01.06.2024; Sage Publications Ltd
• Subjects: Acceptance; Adaptation, Psychological; Adult; Aged; Anxiety - psychology; Attitude to Death; COVID-19; COVID-19 - psychology; Cross-Sectional Studies; Death & dying; Death anxiety; Dialysis; Female; Hemodialysis; Humans; Illnesses; Kidney diseases; Kidney Failure, Chronic - psychology; Kidney Failure, Chronic - therapy; Male; Mental health; Middle Aged; Original Manuscript; Pandemics; Psychological distress; Psychological well being; Psychosocial factors; Quality of life; Quality of Life - psychology; Renal Dialysis - psychology; SARS-CoV-2; Social relations; Surveys and Questionnaires; Covid-19; death anxiety; end-stage renal disease; quality of life; psychological distress
• ISSN: 0030-2228; 1541-3764; 1541-3764
• DOI: 10.1177/00302228221075202

The purpose of the study was to examine the quality of life and illness acceptance among ESRD patients with the moderating effects of death anxiety. The cross-sectional design was incorporated. The sample was comprised of 240 participants. Individuals with ESRD on hemodialysis were approached above 20 years of age. A self-administered questionnaire was used for data collection. The results revealed that COVID-19 has a significant impact on the quality of life of patients and their illness acceptance. Covid-19 affected the general health of patients, their psychological health, as well as their social relationships. The results also confirmed that death anxiety negatively moderates the relationship between quality of life and illness acceptance among ESRD patients. This study will shed light on the need to provide appropriate psychosocial care as well as supportive therapies to people with end-stage renal disease who are experiencing mental distress during and after the COVID-19 outbreak.